Waterloo, Canada

Shengyan (Sandy) Liu

This inventor holds 1 USPTO granted patent. Top assignee: The University of Waterloo. Active years: 2018.


% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 2018

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations of Shengyan (Sandy) Liu

Introduction

Shengyan (Sandy) Liu is an accomplished inventor based in Waterloo, Canada. He has made significant contributions to the field of nanoparticle delivery systems, particularly focusing on mucoadhesive technologies. His work is characterized by a commitment to enhancing drug delivery methods through innovative approaches.

Latest Patents

Shengyan Liu holds a patent for a "Mucoadhesive nanoparticle delivery system." This patent describes a system where nanoparticles are formed from amphiphilic macromolecules conjugated to a mucosal targeting moiety. The design allows for the surface of the nanoparticles to be coated with the targeting moiety, which can be adjusted for optimal targeting to mucosal sites without compromising particle stability. The nanoparticles exhibit high loading efficiency and sustained release properties at the mucosal site. The patent also discusses the polymers and macromolecules useful in preparing these mucoadhesive nanoparticles, along with related compositions, methods, and commercial applications.

Career Highlights

Shengyan Liu is affiliated with the University of Waterloo, where he continues to advance research in nanoparticle technologies. His innovative work has positioned him as a key figure in the development of effective drug delivery systems.

Collaborations

He has collaborated with notable colleagues, including Frank Xiaofei Gu and Lyndon William James Jones, contributing to a dynamic research environment focused on cutting-edge innovations.

Conclusion

Shengyan (Sandy) Liu's contributions to the field of mucoadhesive nanoparticle delivery systems exemplify the potential of innovative technologies in enhancing drug delivery methods. His work continues to inspire advancements in the field.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…